These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1751847)

  • 1. A scale for estimating the health status of opioid users.
    Darke S; Ward J; Zador D; Swift G
    Br J Addict; 1991 Oct; 86(10):1317-22. PubMed ID: 1751847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methadone. Reducing the transmission of HIV].
    Sabourin G
    Perspect Infirm; 2013; 10(3):56. PubMed ID: 23705283
    [No Abstract]   [Full Text] [Related]  

  • 3. [Do we need a methadone maintenance program?].
    Täschner KL
    Nervenarzt; 1991 Sep; 62(9):524-8. PubMed ID: 1956471
    [No Abstract]   [Full Text] [Related]  

  • 4. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
    Altice FL; Friedland GH; Cooney EL
    AIDS; 1999 May; 13(8):957-62. PubMed ID: 10371177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges.
    Klee H; Faugier J; Hayes C; Morris J
    Br J Addict; 1991 Feb; 86(2):217-23. PubMed ID: 2021704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs.
    Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
    Eur Addict Res; 2006; 12(2):74-82. PubMed ID: 16543742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
    Serpelloni G; Carrieri MP; Rezza G; Morganti S; Gomma M; Binkin N
    AIDS Care; 1994; 6(2):215-20. PubMed ID: 8061081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users.
    Darke S; Hall W; Heather N; Ward J; Wodak A
    AIDS; 1991 Feb; 5(2):181-5. PubMed ID: 2031690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
    Otero MJ; Fuertes A; Sánchez R; Luna G
    AIDS; 1999 May; 13(8):1004-5. PubMed ID: 10371190
    [No Abstract]   [Full Text] [Related]  

  • 10. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.
    Camacho LM; Bartholomew NG; Joe GW; Cloud MA; Simpson DD
    Drug Alcohol Depend; 1996 May; 41(1):1-7. PubMed ID: 8793304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.
    Barajas-Nava L
    J Assoc Nurses AIDS Care; 2017; 28(5):832-833. PubMed ID: 28652132
    [No Abstract]   [Full Text] [Related]  

  • 12. Dental management of patients taking methadone.
    Graham CH; Meechan JG
    Dent Update; 2005 Oct; 32(8):477-8, 481-2, 485. PubMed ID: 16262036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk dimensions of HIV-tested substance users.
    Ottomanelli G
    Int J Addict; 1993 Dec; 28(14):1487-95. PubMed ID: 8307661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.
    Kimber J; Copeland L; Hickman M; Macleod J; McKenzie J; De Angelis D; Robertson JR
    BMJ; 2010 Jul; 341():c3172. PubMed ID: 20595255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    Spire B; Lucas GM; Carrieri MP
    Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution treatment of injecting opioid users for prevention of HIV infection.
    Gowing L; Farrell M; Bornemann R; Ali R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004145. PubMed ID: 15495080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.